print PRINT


USTR questions “fairness” of Japan’s drug pricing system

  • April 28, 2018
  • , Sankei
  • JMH Summary

Saturday’s Sankei wrote from Washington that the USTR released on Friday its annual report on intellectual property rights that identifies trading partners that do not adequately or effectively protect and enforce intellectual property rights. The report took up the “transparency and fairness” of Japan’s pharmaceutical pricing and said the USTR intends to address the issue in the U.S.-Japan Economic Dialogue. Sunday’s Mainichi ran a similar Kyodo story.

  • Ambassador
  • Ukraine
  • COVID-19
  • Trending Japan